A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion
PHASE1
The study objectives are to evaluate the safety of a single intravenous (IV...
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
PHASE3
The main objective of this study is to evaluate the efficacy of venetoclax ...
Status
Terminated
Location
Arizona Oncology - Scottsdale - Cancer Transplant Institute /ID# 239711